<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC7091927/results/search/disease/results.xml">
  <result pre="the current state of development of antiviral drugs that target" exact="influenza" post="virus and hepatitis B virus, and the future prospects"/>
  <result pre="of development of antiviral drugs that target influenza virus and" exact="hepatitis" post="B virus, and the future prospects for antivirals from"/>
  <result pre="drugs have been employed. As a result of global efforts," exact="smallpox" post="caused by variola virus infections was eradicated in 1979"/>
  <result pre="by variola virus infections was eradicated in 1979 because of" exact="smallpox" post="vaccination (by vaccinia virus). However, the development of effective"/>
  <result pre="diseases caused by the following nine viruses: HIV, human cytomegalovirus," exact="hepatitis" post="B virus (HBV), hepatitis C virus (HCV), herpes simplex"/>
  <result pre="following nine viruses: HIV, human cytomegalovirus, hepatitis B virus (HBV)," exact="hepatitis" post="C virus (HCV), herpes simplex virus, influenza virus, respiratory"/>
  <result pre="human cytomegalovirus, hepatitis B virus (HBV), hepatitis C virus (HCV)," exact="herpes simplex" post="virus, influenza virus, respiratory syncytial virus, varicella zoster virus"/>
  <result pre="B virus (HBV), hepatitis C virus (HCV), herpes simplex virus," exact="influenza" post="virus, respiratory syncytial virus, varicella zoster virus and human"/>
  <result pre="infections is emerging and re-emerging viruses, such as Ebola virus," exact="severe acute respiratory syndrome" post="coronavirus, Middle East respiratory syndrome coronavirus and Zika virus."/>
  <result pre="Institute of Microbial Chemistry (IMC) and discuss antiviral compounds against" exact="influenza" post="virus and HBV, because these two viruses threaten global"/>
  <result pre="in IMC Compound Viral infections Reference Formycins Influenza virus, poliovirus," exact="vaccinia virus," post="VSV 3, 4 Coformycin HIV 5 Oxanosine HIV 6,"/>
  <result pre="(HIV)d 27, 28 Siastatin B (Influenza virus)e 30 Abbreviations: HBV," exact="hepatitis" post="B virus; HCV, hepatitis C virus; HIV, human immunodeficiency"/>
  <result pre="B (Influenza virus)e 30 Abbreviations: HBV, hepatitis B virus; HCV," exact="hepatitis" post="C virus; HIV, human immunodeficiency virus; HSV, herpes simplex"/>
  <result pre="virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSV," exact="herpes simplex" post="virus; IMC, Institute of Microbial Chemistry; VSV, vesicular stomatitis"/>
  <result pre="herpes simplex virus; IMC, Institute of Microbial Chemistry; VSV, vesicular" exact="stomatitis" post="virus. aInhibition of HIV reverse transcriptase. bInhibition of unknown"/>
  <result pre="anti-HIV drugs against HIV protease. eInhibition of sialidase activity of" exact="influenza" post="virus by epimeric analog of siastatin B. Table 2"/>
  <result pre="infections Reference Spongouridine Spongothymidine (HSV)a 1, 2 Statins HBV, HIV," exact="influenza" post="virus, DENV, HCMV, HCV 101, 102, 103, 104, 105,"/>
  <result pre="HCV 101, 102, 103, 104, 105, 106 Myriocin HCV, HBV," exact="influenza" post="virus 108, 109, 110 NA255 HCV 108 Cyclosporine A"/>
  <result pre="108, 109, 110 NA255 HCV 108 Cyclosporine A HIV, HPV," exact="influenza" post="virus, HBV, HCV, coronaviruses, HCMV 81, 82, 111, 112,"/>
  <result pre="112, 113, 114, 115, 116 Abbreviations: DENV, dengue virus; HBV," exact="hepatitis" post="B virus; HCMV, human cytomegalovirus; HCV, hepatitis C virus;"/>
  <result pre="dengue virus; HBV, hepatitis B virus; HCMV, human cytomegalovirus; HCV," exact="hepatitis" post="C virus; HIV, human immunodeficiency virus; HSV, herpes simplex"/>
  <result pre="cytomegalovirus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSV," exact="herpes simplex" post="virus; HPV, human papillomavirus. aContributed to the synthesis of"/>
  <result pre="of vidarabine (arabinosyladenine), which is used for the treatment of" exact="herpes simplex" post="virus infections. Professor Umezawa and colleagues identified nucleoside analogs"/>
  <result pre="viruses: phleomycin (anti-poliovirus activity),14 fusaric acid (broad-spectrum antiviral activity against" exact="herpes simplex" post="virus, varicella-zoster virus, HBV, HCV and sindbis virus),15 aclacinomycin"/>
  <result pre="siastatin B showed no effect on the sialidase activity of" exact="influenza" post="virus neuraminidase (NA), its epimeric analog significantly inhibited this"/>
  <result pre="unique pharmacophores for antiviral drugs. Influenza virus Influenza virus Seasonal" exact="influenza" post="is acute respiratory infections caused by influenza viruses. There"/>
  <result pre="Influenza virus Seasonal influenza is acute respiratory infections caused by" exact="influenza" post="viruses. There are three types of seasonal influenza viruses—type"/>
  <result pre="caused by influenza viruses. There are three types of seasonal" exact="influenza" post="viruses—type A, B and C; influenza A and B"/>
  <result pre="three types of seasonal influenza viruses—type A, B and C;" exact="influenza" post="A and B viruses cause outbreaks and epidemics. The"/>
  <result pre="The World Health Organization estimates that annual epidemics caused by" exact="influenza" post="A(H1N1), A(H3N2) and B viruses result in ~3 to"/>
  <result pre="severe illness and 250 000 to 500 000 deaths, globally.31 Furthermore, an" exact="influenza" post="pandemic, such as those of the ‘Spanish’ influenza in"/>
  <result pre="Furthermore, an influenza pandemic, such as those of the ‘Spanish’" exact="influenza" post="in 1918 (H1N1),’ ‘Asian’ influenza in 1957 (H2N2),’ ‘Hong"/>
  <result pre="as those of the ‘Spanish’ influenza in 1918 (H1N1),’ ‘Asian’" exact="influenza" post="in 1957 (H2N2),’ ‘Hong Kong’ influenza in 1968 (H3N2),’"/>
  <result pre="in 1918 (H1N1),’ ‘Asian’ influenza in 1957 (H2N2),’ ‘Hong Kong’" exact="influenza" post="in 1968 (H3N2),’ ‘Russian’ influenza in 1977 (H1N1)’ and"/>
  <result pre="in 1957 (H2N2),’ ‘Hong Kong’ influenza in 1968 (H3N2),’ ‘Russian’" exact="influenza" post="in 1977 (H1N1)’ and 2009 H1N1 influenza (swine-origin H1N1),"/>
  <result pre="1968 (H3N2),’ ‘Russian’ influenza in 1977 (H1N1)’ and 2009 H1N1" exact="influenza" post="(swine-origin H1N1), occurs when new influenza A virus against"/>
  <result pre="(H1N1)’ and 2009 H1N1 influenza (swine-origin H1N1), occurs when new" exact="influenza" post="A virus against which the human population has no"/>
  <result pre="discovery and development of new antiviral drugs and vaccines against" exact="influenza" post="infections are required. A total of eight drugs (matrix"/>
  <result pre="(ribavirin and favipiravir) have been approved for the treatment of" exact="influenza" post="infections. M2 inhibitors 1-Adamantanamine (amantadine) was the first synthetic"/>
  <result pre="1-Adamantanamine (amantadine) was the first synthetic compound shown to inhibit" exact="influenza" post="virus propagation33 and was approved in 1966 to treat"/>
  <result pre="influenza virus propagation33 and was approved in 1966 to treat" exact="influenza" post="A virus infections. The target of amantadine is M2"/>
  <result pre="a derivative of amantadine, are not currently used to treat" exact="influenza" post="virus infections because drug-resistant viruses can emerge rapidly (both"/>
  <result pre="in patients treated with amantadine. Figure 1 Life cycle of" exact="influenza" post="virus and anti-influenza virus drugs. Influenza virus is incorporated"/>
  <result pre="(HA) and NA are two major glycoproteins expressed by both" exact="influenza" post="A and B viruses. HA mediates the binding of"/>
  <result pre="from host cells. NA activity facilitates the release of progeny" exact="influenza" post="virus by digesting sialic acids in the HA receptors"/>
  <result pre="of Clostridium perfrigens NAs, but does not inhibit that of" exact="influenza" post="virus (A/Aichi/2/68 strain) NA and Newcastle disease virus (Sato"/>
  <result pre="epimeric analog, 3-episiastatin B, can inhibit the sialidase activity of" exact="influenza" post="A and B viruses NA and propagation of influenza"/>
  <result pre="of influenza A and B viruses NA and propagation of" exact="influenza" post="A virus.30 A synthetic analog of neuraminic acid, 2,3-didehydro-2-deoxy-N-acetylneuraminic"/>
  <result pre="2,3-didehydro-2-deoxy-N-acetylneuraminic acid (Neu5Ac2en), was found to be an inhibitor of" exact="influenza" post="virus NA.36 Neu5Ac2en is considered to be a transition"/>
  <result pre="complex, analogs of Neu5Ac2en were synthesized and the specificity for" exact="influenza" post="virus NA and activity of these analogs were tested."/>
  <result pre="Among these analogs, 4-guanidino-Neu5Ac2en (zanamivir) exhibited antiviral activity against various" exact="influenza" post="A and B viruses.40 The guanidine group in zanamivir"/>
  <result pre="analysis of NA with key analogs.41 One analog, GS4071, inhibited" exact="influenza" post="A virus NA activity. The NA inhibition activity of"/>
  <result pre="These two drugs are used as a single-dose treatment for" exact="influenza" post="A and B viruses. Virus polymerase inhibitors Viral polymerase"/>
  <result pre="PB1 and PB2. At the initiation of viral mRNA transcription," exact="influenza" post="viral polymerase cannot synthesize the 5′-cap structure of mRNA"/>
  <result pre="represents an orally bioavailable compound that is only effective for" exact="influenza" post="A virus, not influenza B virus. S-03318 specifically inhibits"/>
  <result pre="compound that is only effective for influenza A virus, not" exact="influenza" post="B virus. S-03318 specifically inhibits the endonuclease activity of"/>
  <result pre="the cleavage of host pre-mRNAs. S-03318 is effective for both" exact="influenza" post="A and influenza B virus infections. Two approved drugs,"/>
  <result pre="host pre-mRNAs. S-03318 is effective for both influenza A and" exact="influenza" post="B virus infections. Two approved drugs, ribavirin and T-705"/>
  <result pre="virus infections. Two approved drugs, ribavirin and T-705 (favipiravir), inhibit" exact="influenza" post="viral RNA synthesis (Figure 1). Ribavirin is a synthetic"/>
  <result pre="triphosphate form (Ribavirin-TP).48 Ribavirin-TP inhibits the RNA polymerase complex of" exact="influenza" post="virus by competing with ATP and GTP.49 Ribavirin has"/>
  <result pre="ATP and GTP.49 Ribavirin has not been used to treat" exact="influenza" post="virus infection, but has been used for HCV infections"/>
  <result pre="in cells.50, 51 T705-4-ribofuranosyl-5′-triphosphate acts as a specific inhibitor of" exact="influenza" post="virus RNA synthesis. T705-4-ribofuranosyl-5′-triphosphate directly inhibits viral RNA synthesis"/>
  <result pre="exhibit infectivity. T-705 has been approved for use against pandemic" exact="influenza" post="infections in Japan. Natural products for anti-influenza virus infections"/>
  <result pre="estimates in 2016, the annual number of deaths resulting from" exact="viral hepatitis" post="is ~1.4 million, which is comparable to that of"/>
  <result pre="in 2016, the annual number of deaths resulting from viral" exact="hepatitis" post="is ~1.4 million, which is comparable to that of"/>
  <result pre="HBV worldwide and have an elevated risk of developing liver" exact="cirrhosis" post="and hepatocellular carcinoma.60 Current antiviral drugs approved by the"/>
  <result pre="to supply the cccDNA pool. Figure 2 Life cycle of" exact="hepatitis" post="B virus (HBV). HBV enters hepatocytes following binding to"/>
  <result pre="Although nucleos(t)ide analog inhibitors can be highly effective in preventing" exact="liver disease" post="progression, these drugs are not curative and require long-term"/>
  <result pre="HBsAg, which is correlated with dramatic reduction of incidence of" exact="hepatocellular carcinoma." post="However, current nucleos(t)ide inhibitors are ineffective in this regard,"/>
  <result pre="Australia, Hantavirus in the United States, Ebola virus in Africa," exact="severe acute respiratory syndrome" post="and Middle East respiratory syndrome coronaviruses in China and"/>
  <result pre="and Mideast, Zika virus in Oceania and Americas, and the" exact="influenza" post="virus H5N1, H1N1 and H7N2 subtypes. No efficient vaccine"/>
  <result pre="Antiviral effects of stains have been reported for HBV, HIV," exact="influenza" post="virus, dengue virus, human cytomegalovirus and HCV.101, 102, 103,"/>
  <result pre="incarnatum,108 can also inhibit the propagation of HCV, HBV and" exact="influenza" post="virus.108, 109, 110 Serine palmitoyltransferase acts in the sphingomyelin"/>
  <result pre="component of ‘lipid rafts’. Myriocin inhibits the intracellular transport of" exact="influenza" post="virus glycoproteins and NA255 disrupts the HCV replication complex."/>
  <result pre="CsA is effective against viruses such as HIV, human papillomavirus," exact="influenza" post="virus, HCV, coronaviruses and human cytomegalovirus.111, 112, 113, 114,"/>
  <result pre="simulation reveals a multifaceted mechanism of proton permeation through the" exact="influenza" post="A M2 proton channelProc. Natl Acad. Sci. USA20141119396940124979779 35HongMDegradoWFStructural"/>
  <result pre="USA20141119396940124979779 35HongMDegradoWFStructural basis for proton conduction and inhibition by the" exact="influenza" post="M2 proteinNature200845159659918235504 36MeindlPBodoGPalesePSchulmanJTuppyHInhibition of neuraminidase activity by derivatives of"/>
  <result pre="of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acidVirology1974584574634362431 37JanakiramanMNWhiteCLLaverWGAirGMLuoMStructure of" exact="influenza" post="virus neuraminidase B/Lee/40 complexed with sialic acid and a"/>
  <result pre="38TaylorNRvon ItzsteinMMolecular modeling studies on ligand binding to sialidase from" exact="influenza" post="virus and the mechanism of catalysisJ. Med. Chem.1994376166248126701 39ChongAKPeggMSvon"/>
  <result pre="ionisable group involved in binding and catalysis by sialidase from" exact="influenza" post="virusBiochem. Int.1991241651711768256 40von ItzsteinMRational design of potent sialidase-based inhibitors"/>
  <result pre="virusBiochem. Int.1991241651711768256 40von ItzsteinMRational design of potent sialidase-based inhibitors of" exact="influenza" post="virus replicationNature19933634184238502295 41KimCUInfluenza neuraminidase inhibitors possessing a novel hydrophobic"/>
  <result pre="anti-influenza activityJ. Am. Chem. Soc.199711968169016526129 42EisenbergEJBidgoodACundyKCPenetration of GS4071, a novel" exact="influenza" post="neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral"/>
  <result pre="activity of VX-787, a first-in-class, orally bioavailable inhibitor of the" exact="influenza" post="virus polymerase PB2 subunitAntimicrob. Agents Chemother.2015591569158225547360 47ClarkMPDiscovery of a"/>
  <result pre="of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of" exact="influenza" post="PB2J. Med. Chem.2014576668667825019388 48SidwellRWBroad-spectrum antiviral activity of virazole: 1-f8-"/>
  <result pre="antiviral activity of virazole: 1-f8- D-ribofuranosyl- 1,2,4-triazole- 3-carboxamideScience19721777057064340949 49ErikssonBInhibition of" exact="influenza" post="virus ribonucleic acid polymerase by ribavirin triphosphate inhibition of"/>
  <result pre="influenza virus ribonucleic acid polymerase by ribavirin triphosphate inhibition of" exact="influenza" post="virus ribonucleic acid polymerase by ribavirin triphosphateAntimicrob. Agents Chemother.197711946951879760"/>
  <result pre="compound T-705Antimicrob. Agents Chemother.20024697798111897578 51FurutaYMechanism of action of T-705 against" exact="influenza" post="virusAntimicrob. Agents Chemother.20054998198615728892 52JinZSmithLKRajwanshiVKKimBDevalJThe ambiguous base-pairing and high substrate"/>
  <result pre="and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5’-triphosphate towards" exact="influenza" post="A virus polymerasePLoS ONE20138e6834723874596 53BaranovichTT-705 (Favipiravir) induces lethal mutagenesis"/>
  <result pre="A virus polymerasePLoS ONE20138e6834723874596 53BaranovichTT-705 (Favipiravir) induces lethal mutagenesis in" exact="influenza" post="A H1N1 viruses in vitroJ. Virol.2013873741375123325689 54SangawaHMechanism of action"/>
  <result pre="vitroJ. Virol.2013873741375123325689 54SangawaHMechanism of action of T-705 ribosyl triphosphate against" exact="influenza" post="virus RNA polymeraseAntimicrob. Agents Chemother.2013575202520823917318 55GrienkeUInfluenza neuraminidase: a druggable"/>
  <result pre="63YanHSodium taurocholate cotransporting polypeptide is a functional receptor for human" exact="hepatitis" post="B and D virusElife20121128 64Hepatitis B Foundation. Treatment &amp;amp;"/>
  <result pre="oxetanocin G, a novel nucleoside analog, on DNA synthesis by" exact="hepatitis" post="B virus virionsAntimicrob. Agents Chemother.1994387077127518217 67NagahataTUedaKTsurimotoTChisakaOMatsubaraKAnti-hepatitis B virus activities"/>
  <result pre="oxetanocin AJ. Antibiot. (Tokyo)1989426446462722678 68WangXEmerging antivirals for the treatment of" exact="hepatitis" post="BWorld J. Gastroenterol.201420770724976708 69SummersJSmithPMHorwichALHepadnavirus envelope proteins regulate covalently closed"/>
  <result pre="closed circular DNA amplificationJ. Virol.199064281928242335817 70LevreroMControl of cccDNA function in" exact="hepatitis" post="B virus infectionJ. Hepatol.20095158159219616338 71YangLIsothiafludine, a novel non-nucleoside compound,"/>
  <result pre="B virus infectionJ. Hepatol.20095158159219616338 71YangLIsothiafludine, a novel non-nucleoside compound, inhibits" exact="hepatitis" post="B virus replication through blocking pregenomic RNA encapsidationActa Pharmacol."/>
  <result pre="through blocking pregenomic RNA encapsidationActa Pharmacol. Sin.20143541041824487969 72YangLEffect of a" exact="hepatitis" post="B virus inhibitor, NZ-4, on capsid formationAntiviral Res.2016125253326611395 73HuYChengXCaoFHuangATavisJEβ-Thujaplicinol"/>
  <result pre="B virus inhibitor, NZ-4, on capsid formationAntiviral Res.2016125253326611395 73HuYChengXCaoFHuangATavisJEβ-Thujaplicinol inhibits" exact="hepatitis" post="B virus replication by blocking the viral ribonuclease H"/>
  <result pre="blocking the viral ribonuclease H activityAntiviral Res.20139922122923796982 74LuGHydroxylated tropolones inhibit" exact="hepatitis" post="B virus replication by blocking viral ribonuclease H activityAntimicrob."/>
  <result pre="by Streptoverticillium hadanonense KY11449J. Antibiot. (Tokyo)1986395895933086266 76SuzukiMEfficient genome replication of" exact="hepatitis" post="B virus using adenovirus vector: a compact pregenomic RNA-expression"/>
  <result pre="adenovirus vector: a compact pregenomic RNA-expression unitSci. Rep.201774185128157182 77GehringABertolettiATavisJEHost factor-targeted" exact="hepatitis" post="B virus therapiesIntervirology20145715816225034483 78EzzikouriSRecent insights into hepatitis B virus-host"/>
  <result pre="Rep.201774185128157182 77GehringABertolettiATavisJEHost factor-targeted hepatitis B virus therapiesIntervirology20145715816225034483 78EzzikouriSRecent insights into" exact="hepatitis" post="B virus-host interactionsJ. Med. Virol.20148692593224604126 79GriponPCannieIUrbanSEfficient inhibition of hepatitis"/>
  <result pre="into hepatitis B virus-host interactionsJ. Med. Virol.20148692593224604126 79GriponPCannieIUrbanSEfficient inhibition of" exact="hepatitis" post="B virus infection by acylated peptides derived from the"/>
  <result pre="blocks intrahepatic virus spreading in humanized mice previously infected with" exact="hepatitis" post="B virusJ. Hepatol.20135886186723246506 81NkongoloSCyclosporin A inhibits hepatitis B and"/>
  <result pre="previously infected with hepatitis B virusJ. Hepatol.20135886186723246506 81NkongoloSCyclosporin A inhibits" exact="hepatitis" post="B and hepatitis D virus entry by cyclophilin-independent interference"/>
  <result pre="hepatitis B virusJ. Hepatol.20135886186723246506 81NkongoloSCyclosporin A inhibits hepatitis B and" exact="hepatitis" post="D virus entry by cyclophilin-independent interference with the NTCP"/>
  <result pre="the NTCP receptorJ. Hepatol.20146072373124295872 82WatashiKCyclosporin A and its analogs inhibit" exact="hepatitis" post="B virus entry into cultured hepatocytes through targeting a"/>
  <result pre="membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)Hepatology2014591726173724375637 83BlockTMSecretion of human" exact="hepatitis" post="B virus is inhibited by the imino sugar N-butyldeoxynojirimycinProc."/>
  <result pre="tick-borne flavivirusesAntiviral Res.2017142636728336346 97JulanderJGBCX4430, a novel nucleoside analog, effectively treats" exact="yellow fever" post="in a hamster modelAntimicrob. Agents Chemother.2014586607661425155605 98JulanderJGEfficacy of the"/>
  <result pre="for combination therapy with interferonHepatology20064411712516799963 103PengJProtective effect of fluvastatin on" exact="influenza" post="virus infectionMol. Med. Rep.201492221222624676773 104GiguèreJTremblayMJStatin compounds reduce human immunodeficiency"/>
  <result pre="arbomycesJ. Antibiot. (Tokyo)197222109115 108SakamotoHHost sphingolipid biosynthesis as a target for" exact="hepatitis" post="C virus therapyNat. Chem. Biol.2005133333716408072 109TatematsuKTanakaYSugiyamaMSudohMMizokamiMHost sphingolipid biosynthesis is"/>
  <result pre="biosynthesis is a promising therapeutic target for the inhibition of" exact="hepatitis" post="B virus replicationJ. Med. Virol.20118358759321328371 110TafesseFGIntact sphingomyelin biosynthetic pathway"/>
  <result pre="110TafesseFGIntact sphingomyelin biosynthetic pathway is essential for intracellular transport of" exact="influenza" post="virus glycoproteinsProc. Natl Acad. Sci. USA20131106406641123576732 111Bienkowska-HabaMWilliamsCKimSMGarceaRLSappMCyclophilins facilitate dissociation"/>
  <result pre="as target for pan-coronavirus inhibitorsPLoS Pathog.20117e100233122046132 114LiuXCyclosporin A inhibits the" exact="influenza" post="virus replication through cyclophilin A-dependent and -independent pathwaysPLoS ONE2012718"/>
  <result pre="replication and reactivationJ. Gen. Virol.20129372273222238232 116WatashiKHijikataMHosakaMYamajiMShimotohnoKCyclosporin A suppresses replication of" exact="hepatitis" post="C virus genome in cultured hepatocytesHepatology2003381282128814578868 117MatsudaSKoyasuSMechanisms of action"/>
 </snippets>
</snippetsTree>
